WHITLEY HOUSE SURGERY — All Prescriptions & Medications — Page 3
Practice Code: F81057 | CHELMSFORD, CM1 3RW
Showing results 101-150 of 607
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Nortriptyline | 497 | 26.2K | £2.2K | +241.6% ▲ |
| Alogliptin | 490 | 14.0K | £12.6K | +93.2% ▲ |
| Mesalazine (Systemic) | 482 | 48.5K | £26.1K | +101.2% ▲ |
| Aripiprazole | 477 | 9,660 | £1.3K | +87.5% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 464 | 39.3K | £1.5K | +51.4% ▲ |
| Carbamazepine | 463 | 46.1K | £2.7K | +56.0% ▲ |
| Enalapril maleate | 450 | 19.0K | £763 | +150.4% ▲ |
| Insulin glargine | 449 | 2,689 | £18.9K | +58.1% ▲ |
| Tramadol hydrochloride | 446 | 35.0K | £1.9K | -37.8% ▼ |
| Warfarin sodium | 442 | 21.6K | £748 | -6.3% ▼ |
| Famotidine | 438 | 14.6K | £7.9K | -10.2% ▼ |
| Methotrexate | 437 | 7,688 | £7.0K | +34.3% ▲ |
| Trimethoprim | 435 | 12.4K | £823 | +112.9% ▲ |
| Senna | 434 | 18.8K | £433 | -27.9% ▼ |
| Escitalopram | 424 | 10.3K | £653 | +49.0% ▲ |
| Betamethasone valerate | 419 | 33.2K | £2.2K | +8.8% ▲ |
| Cetirizine hydrochloride | 409 | 38.5K | £2.2K | -18.1% ▼ |
| Lithium carbonate | 403 | 12.8K | £2.0K | +217.7% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 403 | 17.0K | £1.4K | +163.9% ▲ |
| 403 | 451 | £512 | +82.9% ▲ | |
| Estradiol | 393 | 9,403 | £5.1K | +45.7% ▲ |
| Digoxin | 383 | 11.6K | £841 | +1.2% vs avg |
| Bumetanide | 383 | 13.3K | £1.3K | +40.6% ▲ |
| 381 | 391 | £17.1K | +22.7% ▲ | |
| Pravastatin sodium | 373 | 12.6K | £603 | +14.9% ▲ |
| Lactulose | 360 | 212.4K | £2.0K | +9.3% ▲ |
| Fluticasone furoate | 360 | 368 | £2.5K | +85.8% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 355 | 38.3K | £2.8K | +57.1% ▲ |
| Sacubitril/valsartan | 354 | 14.3K | £23.3K | +47.8% ▲ |
| Clarithromycin | 350 | 9,466 | £1.6K | +42.6% ▲ |
| Diclofenac diethyl | 348 | 41.6K | £2.8K | -2.0% ▼ |
| Sodium valproate | 346 | 46.0K | £5.6K | +8.8% ▲ |
| 346 | 5,750 | £3.4K | -47.9% ▼ | |
| Timolol and bimatoprost | 344 | 3,147 | £4.6K | +126.7% ▲ |
| Verapamil hydrochloride | 340 | 8,757 | £1.5K | +274.7% ▲ |
| 337 | 342 | £2.1K | +42.7% ▲ | |
| Flecainide acetate | 332 | 18.5K | £696 | +325.2% ▲ |
| Tolterodine | 329 | 10.3K | £1.9K | +121.3% ▲ |
| Umeclidinium bromide/vilanterol | 324 | 333 | £10.3K | +66.2% ▲ |
| Hydroxychloroquine sulfate | 322 | 16.7K | £867 | +66.3% ▲ |
| Empagliflozin | 317 | 9,716 | £12.1K | -49.3% ▼ |
| Letrozole | 317 | 9,616 | £878 | +69.8% ▲ |
| Tiotropium bromide | 312 | 2,106 | £7.9K | +2.6% ▲ |
| Mebeverine hydrochloride | 310 | 26.0K | £1.2K | -0.2% vs avg |
| Lisinopril | 307 | 11.7K | £258 | -72.0% ▼ |
| Donepezil hydrochloride | 301 | 5,091 | £1.5K | -2.5% ▼ |
| Cyanocobalamin | 295 | 10.5K | £1.6K | -16.4% ▼ |
| Perindopril erbumine | 286 | 9,126 | £761 | -46.1% ▼ |
| Vortioxetine | 276 | 4,382 | £4.1K | +297.7% ▲ |
| Mometasone furoate | 273 | 15.2K | £1.5K | +104.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.